Recommend to a friend

Applying the Evidence on Antifibrotic Agents for IPF

Drs. David J. Lederer and Fernando J. Martinez address the following topics:
  • How should patients be managed who experience disease progression while on antifibrotic therapy?
  • Is there enough evidence on mortality with antifibrotic therapy to discuss this with patients?
No image set